Compare ICU & DTSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICU | DTSS |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1M | 9.0M |
| IPO Year | N/A | 2015 |
| Metric | ICU | DTSS |
|---|---|---|
| Price | $2.53 | $0.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 53.7K | 30.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 82.42 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $71,616,820.00 |
| Revenue This Year | $1,043.70 | N/A |
| Revenue Next Year | $54.99 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 198.70 |
| 52 Week Low | $0.22 | $0.64 |
| 52 Week High | $2.98 | $2.70 |
| Indicator | ICU | DTSS |
|---|---|---|
| Relative Strength Index (RSI) | 55.54 | 42.76 |
| Support Level | $2.26 | $0.81 |
| Resistance Level | $2.73 | $0.98 |
| Average True Range (ATR) | 0.17 | 0.08 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 41.32 | 37.52 |
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).